These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16612400)

  • 1. Selection of contrast media.
    Solomon R; Briguori C; Bettmann M
    Kidney Int Suppl; 2006 Apr; (100):S39-45. PubMed ID: 16612400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.
    Biondi-Zoccai G; Lotrionte M; Thomsen HS; Romagnoli E; D'Ascenzo F; Giordano A; Frati G
    Int J Cardiol; 2014 Mar; 172(2):375-80. PubMed ID: 24502883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current evidence on prevention and management of contrast-induced nephropathy.
    Thomsen HS
    Eur Radiol; 2007 Dec; 17 Suppl 6():F33-7. PubMed ID: 18376455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-induced nephropathy.
    Persson PB
    Eur Radiol; 2005 Nov; 15 Suppl 4():D65-9. PubMed ID: 16479650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs.
    Elmståhl B; Nyman U; Leander P; Chai CM; Frennby B; Almén T
    Acad Radiol; 2004 Nov; 11(11):1219-28. PubMed ID: 15561568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
    Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
    Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
    McCullough PA; Bertrand ME; Brinker JA; Stacul F
    J Am Coll Cardiol; 2006 Aug; 48(4):692-9. PubMed ID: 16904536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is contrast medium osmolality a causal factor for contrast-induced nephropathy?
    Bucher AM; De Cecco CN; Schoepf UJ; Meinel FG; Krazinski AW; Spearman JV; McQuiston AD; Wang R; Bucher J; Vogl TJ; Katzberg RW
    Biomed Res Int; 2014; 2014():931413. PubMed ID: 24800254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular gadolinium-based contrast media: an overview.
    Bellin MF; Van Der Molen AJ
    Eur J Radiol; 2008 May; 66(2):160-7. PubMed ID: 18358659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Contrast-Induced Nephropathy-The Rise and Fall of a Threatening Idea.
    Luk L; Steinman J; Newhouse JH
    Adv Chronic Kidney Dis; 2017 May; 24(3):169-175. PubMed ID: 28501080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
    Downes MO; Nicholson A
    Clin Radiol; 2010 Apr; 65(4):343-4; author reply 344-5. PubMed ID: 20338404
    [No Abstract]   [Full Text] [Related]  

  • 12. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
    [No Abstract]   [Full Text] [Related]  

  • 14. Contrast medium-induced nephropathy: the pathophysiology.
    Persson PB; Tepel M
    Kidney Int Suppl; 2006 Apr; (100):S8-10. PubMed ID: 16612403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
    Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
    Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of contrast-induced nephropathy with volume supplementation.
    Mueller C
    Kidney Int Suppl; 2006 Apr; (100):S16-9. PubMed ID: 16612395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-low iodine concentrations iso-attenuating with diagnostic 0.5M gadolinium in endovascular procedures to minimize the risk of contrast nephropathy: A phantom study.
    Swanberg J; Åslund PE; Nyman RS; Nyman UR
    Eur J Radiol; 2015 Jun; 84(6):1068-74. PubMed ID: 25842009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast nephropathy: isosmolar and low-osmolar contrast media.
    Detrenis S; Meschi M; Savazzi G
    J Am Coll Cardiol; 2007 Feb; 49(8):922; author reply 922-3. PubMed ID: 17320755
    [No Abstract]   [Full Text] [Related]  

  • 20. Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
    Morcos SK
    Clin Radiol; 2009 May; 64(5):468-72. PubMed ID: 19348841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.